Literature DB >> 19858572

Ventilator-associated nosocomial pneumonia in intensive care units in Malaysia.

Supaletchimi Gopal Katherason1, Lin Naing, Kamarudin Jaalam, Kamarul Imran Musa, Nik Abdullah Nik Mohamad, Subramaniar Aiyar, Kavita Bhojani, Najah Harussani, Aisai Abdul Rahman, Asma Ismail.   

Abstract

BACKGROUND: The outcome indicator of nosocomial infection (NI) in the intensive care unit (ICU) is used to benchmark the quality of patient care in Malaysia. We conducted a three-year prospective study on the incidences of ventilator-associated pneumonia (VAP), risk factors, and patterns of the microorganisms isolated in three ICUs.
METHODOLOGY: A follow-up in prospective cohort surveillance was conducted on patients admitted to an adult medical-surgical ICU of a university hospital and two governmental hospitals in Malaysia from October 2003 to December 2006. VAP was detected using CDC criteria which included clinical manifestation and confirmed endotracheal secretion culture results.
RESULTS: In total, 215 patients (2,306 patient-days) were enrolled into the study. The incidence of ICU-acquired device-related NI was 29.3 % (n = 63). The device-related VAP infection rate was 27.0 % (n = 58), with a mechanical ventilator utilization rate of 88.7%. The death rate due to all ICU-acquired NI including sepsis was 6.5%. The most common causative pathogen was Klebsiella pneumoniae (n = 27). Multivariate analysis using Cox regression showed that the risk factors identified were aspiration pneumonia (HR = 4.09; 95% CI = 1.24, 13.51; P = 0.021), cancer (HR = 2.51; 95% CI = 1.27, 4.97; P = 0.008), leucocytosis (HR=3.43; 95% CI= 1.60, 7.37; P=0.002) and duration of mechanical ventilation (HR=1.04; 95% CI = 1.00, 1.08; P = 0.030). Age, gender and race were not identified as risk factors in the multivariable analysis performed.
CONCLUSION: The incidence of VAP was comparable to that found in the National Nosocomial Infection Surveillance (NNIS) System report of June 1998. The incidence of VAP was considered high for the three hospitals studied.

Entities:  

Mesh:

Year:  2009        PMID: 19858572     DOI: 10.3855/jidc.115

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  6 in total

1.  Risk factors for acquisition of ventilator-associated pneumonia in adult intensive care units.

Authors:  Fariba Lahoorpour; Ali Delpisheh; Abdorrahim Afkhamzadeh
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

2.  Precalcitonin and C-reactive protein as markers in response to antibiotic treatment in ventilator-associated pneumonia in intensive care unit-hospitalized patients.

Authors:  Babak Ali Kiaei; Farzin Ghiasi; Daryoush Moradi
Journal:  Adv Biomed Res       Date:  2015-10-29

3.  Device-associated infection rates, mortality, length of stay and bacterial resistance in intensive care units in Ecuador: International Nosocomial Infection Control Consortium's findings.

Authors:  Estuardo Salgado Yepez; Maria M Bovera; Victor D Rosenthal; Hugo A González Flores; Leonardo Pazmiño; Francisco Valencia; Nelly Alquinga; Vanessa Ramirez; Edgar Jara; Miguel Lascano; Veronica Delgado; Cristian Cevallos; Gasdali Santacruz; Cristian Pelaéz; Celso Zaruma; Diego Barahona Pinto
Journal:  World J Biol Chem       Date:  2017-02-26

4.  Exploring the competency of the Jordanian intensive care nurses towards endotracheal tube and oral care practices for mechanically ventilated patients: an observational study.

Authors:  Abdul-Monim Mohammad Batiha; Ibrahim Bashaireh; Mohammed Albashtawy; Sami Shennaq
Journal:  Glob J Health Sci       Date:  2012-12-24

5.  Resistance of gram negative bacteria in hospital acquired pneumonia: a prospective study.

Authors:  Farzaneh Dehghan; Nader Zolghadri; Vahid Boostani; Afsaneh Shafii; Tasnim Eghbal Eftekhaari
Journal:  Braz J Infect Dis       Date:  2015-12-22       Impact factor: 3.257

6.  A scoping review of registry captured indicators for evaluating quality of critical care in ICU.

Authors:  Issrah Jawad; Sumayyah Rashan; Chathurani Sigera; Jorge Salluh; Arjen M Dondorp; Rashan Haniffa; Abi Beane
Journal:  J Intensive Care       Date:  2021-08-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.